Literature DB >> 2865516

Comparison between a physiological and a pharmacological stimulus of growth hormone secretion: response to stage IV sleep and insulin-induced hypoglycaemia.

P C Hindmarsh, P J Smith, B J Taylor, P J Pringle, C G Brook.   

Abstract

Peak growth hormone (GH) response to insulin-induced hypoglycaemia was compared with peak GH concentration during the first cycle of stage IV sleep in 75 children. 65 children had concordant results: in 38 GH concentrations were greater than 15 mU/l and in 27 less than this value. Results were discordant in 10 children. Results of sleep sampling under electroencephalographic control of the assessment of GH secretion are comparable to conventional pharmacological studies in terms of efficiency, sensitivity, and percentage false-negatives. Sleep sampling has the advantage of being a physiological test of secretion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865516     DOI: 10.1016/s0140-6736(85)90906-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Urinary growth hormone excretion as a screening test for growth hormone deficiency.

Authors:  J M Walker; P J Wood; S Williamson; P R Betts; A J Evans
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

Review 2.  An assessment of growth hormone provocation tests.

Authors:  P C Hindmarsh; P G Swift
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

Review 3.  Screening tests for growth hormone deficiency.

Authors:  A J Evans
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

4.  Combined use of vasopressin and synthetic hypothalamic releasing factors as test of anterior pituitary function.

Authors:  A Grossman; J A Wass; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-10

5.  Circulating immunoreactive growth hormone releasing hormone concentrations and growth hormone response to growth hormone releasing hormone in short children.

Authors:  P J Tapanainen
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.